HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Late occurrence of chronic immune-mediated axonal polyneuropathy following bone marrow transplant for juvenile-onset alpha-mannosidosis.

Abstract
A 23-year-old woman with juvenile-onset alpha-mannosidosis developed an axonal polyneuropathy more than a year following successful unrelated donor (URD) BMT complicated by chronic graft-versus-host disease (GVHD). Progressive muscle weakness and paresthesias developed over at least 4 months, and made her nonambulatory. Nerve conduction and EMG studies demonstrated an axonal sensorimotor neuropathy. Cerebral spinal fluid (CSF) IgG was elevated with two peaks not identified in serum. Strength improved after a single course of plasma exchange and continued to improve over 12 months. The response to plasma exchange, elevated CSF IgG production, and evidence of a serum IgM peak suggest an immune-mediated mechanism. Chronic polyneuropathies following BMT are rare and are usually temporally related to GVHD or infection. This patient's disease was unusual because of its late occurrence and chronic onset in the face of resolved GVHD and in the absence of infection.
AuthorsD A Mulrooney, S M Davies, D Walk, L R Charnas
JournalBone marrow transplantation (Bone Marrow Transplant) Vol. 32 Issue 9 Pg. 953-5 (Nov 2003) ISSN: 0268-3369 [Print] England
PMID14561998 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Axons
  • Bone Marrow Transplantation (adverse effects, methods)
  • Chronic Disease
  • Female
  • Humans
  • Plasma Exchange
  • Polyneuropathies (etiology, immunology, therapy)
  • Time
  • Transplantation, Homologous
  • Treatment Outcome
  • alpha-Mannosidosis (complications, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: